Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
435 Cards in this Set
- Front
- Back
alpha 2 agonist
|
decrease SANS outflow , AE- edema and CNS dep , DI- TCA decrease antiHTN effects
|
|
clonidine
|
alpha 2 agonist, opiate withdrawal
|
|
methyldopa
|
alpha 2 agonist, HTN in preg women , AE- + coombs
|
|
reserpine
|
intereferes with storage vesicles, SEVERE DEPRESSION, increased GI secretions , depletes NE, 5HT, DA
|
|
guanethidine
|
inhibits NE release, AE- TCA block reuptake
|
|
alpha 1 blocker
|
decrease arteriloar ad venous resiscntace, reflexc tachycarida, -zosin, USE- HTN and BPH, AE- orthostatic hypotention and urinary incon, good lipid profile
|
|
B blockers
|
CI- diabetics, vasopsoams, asthma
|
|
hydralazine
|
decrease TPR via arteriolrar dilation,SLE like syn, use for pregnancy , act via NO2
|
|
nitroprusside
|
AE- CN toxicity, use- HTN emergecy , act via NO2
|
|
minoxidil
|
arteriolar vasoldation, open K channles , USE- male baldness(rogaine) AE- diabetogenic(decreases insulin)
|
|
CCBs
|
antiartyhmic, HTN, angina, AE- ginigival hyperplasia(dipines), verampil
|
|
verampil
|
CCB that works on hrt , AE- constipation
|
|
DIPINE
|
CCB that works on blood vessel
|
|
dialtezam
|
CCB that can work on hert and blood vessel
|
|
captopril
|
ACEI, blocks form of Ang II, AE- dry cough, hyperkalemia, ARF, angioedema , USE- mild to mod HTN, CHF
|
|
losaratan
|
block AT1 receptor, no dry cough , USE- mild to mod HTN, CHF
|
|
aliskerin
|
renin inhibitors, no dry cought, USE- mild to mod HTN
|
|
ANTI HTN in angina
|
B blockers, CCBs
|
|
ANTI HTN in diabetes
|
ACEI, ARBs
|
|
ANTI HTN in HF
|
ACEI, ARBs, Beta blockers
|
|
ANTI HTN in post MI
|
B blockers
|
|
ANTI HTN in BPH
|
alpha blockers
|
|
ANTI HTN in dyslpipidemia
|
alpha blockers, CCBs, ACEI/ ARB
|
|
Bosetan
|
vasoconstrictior, CI- pregnancy ,USE- pu; HTN
|
|
epoprosteronol
|
infusion pump for pul HTN
|
|
sildenafil
|
PDE inh, increased cGMP, USE- pul HTN
|
|
methoxamine
|
paraxysmal atrial tachycarida through vagal refelx
|
|
isoproteronol
|
B1 and B3 agonist, USE- bronchospasm and AV block, AE0 flushing
|
|
Dobutamine
|
B1 agonsit, USE- CHF
|
|
selevctive B2
|
salemterol, albuterol, terbutaline used in asthma
|
|
methy phenidate
|
use in narcolepsy and ADHD, displaces NE from mobile pool
|
|
reuptake inhibitor
|
cocaine and TCA
|
|
mirtazapine
|
selective alpha 2 blocker, used as antidepressent, increases appetite- USE- anorexia
|
|
timolol
|
glaucoma , blocks action of NE, decrease aqueosu humor formation, for open glucoma
|
|
propranol
|
thyrotoxicosis, performance anxiety, essential tremor , essential trempor, agoraphobia, social phobia
|
|
sotalol
|
K channel blocking and B blocking , slows phase III, B 1 blockage, USE- life threatening ventricular arrthmias
|
|
pilocarpine
|
increases aqueous humor outflow, for glaucoma , M3- ocntraction of cilirary muscle
|
|
Quinidine
|
cinchonism(GI, ocular dysfunction, CNS exlciation), torsades, DI- hyperkalemia, toxic with digoxin, Class IA
|
|
procainamide
|
IA antiarrthmic, AE- SLE like syn, torsades , hematoxcity, thrombocytopenia
|
|
IA antiarrthmic
|
block open or activated state Na channels
|
|
IB antiarrthmic
|
preference for damaged tissue, prefers partially depoalzied tissue, lidocaine, mexiletene
|
|
lidocaine
|
IB, post MI, AE- sexiures, less cardiotxoicity
|
|
mexiletine
|
IB antiarrthmic
|
|
flecainadie
|
IC, increased sudden death,
|
|
esmolol
|
IV, acute SVTs, beta blocker
|
|
B blocker as antiarthmcis
|
prophylasix post MI, SVTs , decrease slope of phase 4 of AP in SA node
|
|
Ventricular arrthmias
|
IA, III
|
|
SVTs
|
II, IV
|
|
III antiarthmics
|
decreas IK(delayed rectified) sloe down phase 3, amiodarone, sotalol
|
|
amiodarone
|
I, II, III, IV, long half life, AE- pul fibrosis, hepatoxicity, thyroid dysnfcion, blue skin( high Vd)
|
|
adenosine
|
DOC for paroxysmal supraventricualr tachycardias and AV nodal arrythmias, short half life
|
|
Magnesium
|
USE- torsades
|
|
digoxin
|
inh of cardiac Na K ATPase, increased intracellular CA, increased contractile force , inhibition of neuronal NaK ATPase-->increased diastolic filing, INCREASED CONTRACTILITY , long half life, large tissue protein bomding, USE- CHF, SVT, AE- anorexia, CNS, arrthmias, MANGEMENT- Fab antibodies
|
|
inamironone and milrinoine
|
increase cAMP in hrt, increased ionotropy, increased cAMP in smooth muscle--> decreased TPR
|
|
Nesiritide
|
recomb BNP, increased cGMP , use for acute decompensated CHF
|
|
nitroglycerin
|
AE- orthostatic hypertension, tachyphylaxis, cadiotox with digoxin, USE- angina
|
|
nefidipine
|
CCB used for vaspospastic angina
|
|
carvedilol
|
angina of effort
|
|
ranolazine
|
blocks late inward Na current in cardiac myocytes decreasing Ca acculumation( Ca accumulates in ischemic tissue to due increased Na)
|
|
theophylline
|
PDE inhibitors, tx for status epilepticius, AE- carditoxicity
|
|
Acetazolamide
|
CA inh in PT, decreased H in PCT, increased Na and HCO3 in lumen,USE- galucoma, acute mountain sickes, metabolic alkalisis, AE- ACIDOSIS, RENAL STONES, SULFONAMIDE HYPERSENSITIVTY , dx- INCREASED HCO3 in urine
|
|
Mannitol
|
inhbits water reabsortions through out the tubule, increased urine volumne
|
|
Ethacrinic acid
|
loop diurecti, no allergies to sulfanamide, INCREASED Ca in urine
|
|
Furosemide
|
loop diurecti, allergies to sulfanamide, INCREASED Ca in urine , USE- acute pul edema
|
|
Thiazides
|
Na Cl transport inhibitor in EARLY DISTAL, USE- calcium stones, AE- HYPERCALCEMIA, nephrogenic DI , CI in diabetics but can be given as antihypertinces(works well with AA men) , drugs- indapamide, metolazone, hydrocholrothiazide
|
|
Spironolactone
|
early collecting duct , aldosterone antagonist, uSE- antiandrogenic, CHF, AE- hyperkalemia+acidosis
|
|
Amiloride and triamterone
|
Na channel blockers, USE-LI induced nephrogenic diabetes(amiloride), AE- hyperkalemia+acidosis
|
|
Loops
|
Na/K/Cl transport inhibitor in ASCENDING LIMB, INCREASED Ca in urine , ethacrinic acid, furosemide , USE- acute pul edema, ARF , AE- otoxicity, DI- aminoglycosides(increased otoxictiy), lithium, digoxin
|
|
lovastatin
|
HMG CoA reductase, MOA- decreased VLDL synthesis and decreased LDL, AE- rhabdomyolysis, hepatoxicity, DI with gemfibrozil(increased rhabdomyolsis), increased toxcitiy with CYP 450 inh
|
|
cholestryamine and colestipol
|
bile acid sequenstrant, increaed LDL expression, AE- increased VLDL and TAGs, MALABSORPTION OF FAT SOLUBLE VITAMINS , CI- hypertriglycerderimia
|
|
niacin
|
inhibition of VLDL syntehsis, decreased VLDL, AE- intesse PRURITIS made better with aspirin
|
|
gemfibrozil, fenofibrate
|
fibrates, bind to PPAR alpha and increase expression of lipoprotein lipases, increases HDL in most pts, USE- hypertriglycedemia, AE- gall stones, myositis
|
|
ezetimibe
|
prevents intestinal reabsorption of cholestrol
|
|
drug for increased cholestrol
|
cholestryamine, colestipol, ezetimibe
|
|
drug for increased TAG
|
gemfibrozil
|
|
drug for increased cholestrol and triglycerides
|
statins, niacin, ezetimibe
|
|
alprozolam
|
anxiety, panic phobias
|
|
diazepam
|
anxiety, muscle relaxant
|
|
lorazepam
|
anxiety, status epilepticus , not metabolized by liver
|
|
midazolam
|
preop sedation, anesthesia , anterograde amnesia(BZ2)
|
|
teazepam and oxazepam
|
sleep disorder benzo , not metabolized by liver
|
|
phenobarbitol
|
barbituate, DOC for epilepsy during pregnancy
|
|
thiopental
|
short acting, anesthesia, barbituate , works on GABA A(Cl), complex I inhibitor
|
|
zolpidem and zaleplon
|
BZ1 receptor agonist, sleep disorders(less effect on cognition)
|
|
barbituates
|
CYP inducer, CI in porphyria
|
|
busipirone
|
5HTA partial agonist, used for GAD
|
|
|
|
|
methanol
|
results in formaldehyde- irreversible tisue damage, ocular damage, resp failure
|
|
ethylene glycol
|
reumts in production of oxalic acid, nephrotoic acid, CNS depression
|
|
ethanol
|
results in acetic acid, acetaldehyde combines with folate to inactivate it, combies with thiamine to decrease availability
|
|
disulfiram
|
inhibits acetaldehyde dehydrogenase, similar rxn with- metronidazole, griseofulvin, cefoperazone, cefotetan, chlorpropramide
|
|
chronic alcoholism
|
msucle wasting, gout, fatty liver, hypoglycemia
|
|
Phenytoin
|
blocks Na channel in their inactivated state, USE- seziures except absence, PK- zero order kinetics, AE- gingival hyperlasia, hirsuitism, osteomalacia, megaloblastic anemia, TERATOGENIC( cleft lip and palate)
|
|
Carbamazepine
|
blocks Na chaniinel in activated state, DOC- trigem neuralgia, used for manic bipolar disorder, PK- CYP 450 inducer, AE- INCREASED ADH, steven johnson syndrome, TERATOGENIC( spina bifida and cleft lip and palate)
|
|
valproic acid
|
GABA transaminas inibitor, blcokage of T type Ca channels, USE- migraine prophylaxis, mania of bipolar disorders, AE- pancreatitis, alopecia, TERATOGEIC( spina bifida)
|
|
Ethosuximide
|
blockage of T type Ca, USE- absence seizure, AE- decreased efficacy of oral contraceptives via CYP induction
|
|
felbamate and lamitrigine
|
block Na channels and glutamate receptors , AE- hepattoxcitiy and aplastic anemia(felbamate), steven johnson( lamotrigine)
|
|
gabapentin
|
increased GABA effects, USE- neuropathic pain
|
|
NO2
|
diffusion hypoxia, spon abortion, low blood gas, rapid onset and recovery, high MAC
|
|
halothate
|
low MAC, higher blood gas ratio, malignant hyperthermia, cardiac arrythmias
|
|
profol
|
antiemetic, anesthesia- initation and maitaines
|
|
fentanyl
|
opiate, anesteha
|
|
ketamine
|
dissociative anethesia, NMDA receptor antagonist, hallucination, increased ICP, vivid nightmares
|
|
felbamate
|
anesthetic blocking NMDA receptor
|
|
tetrodotoxin
|
puffer fish. Block inactivated Na channels, decreased Na influex
|
|
ciguatoxin
|
bind to activated Na channle, cause inactvation, prolong Na influx, desesensitixe and inactivate
|
|
esters
|
procaine, cocaine, cause allergeis due to PABA(paraaminobenzoic acid)
|
|
amides
|
lidocaine, bupivacaine
|
|
local analgesics
|
nonionized form crosses axoimanl membrane, from within ionized form blocks the inacticated Na channel, slows recovery and prevents propogation of action potentials, esters and amides, AE- cadiotxoic,, neruotoxic
|
|
cocaine
|
vasocontiction by blocking NE uptake
|
|
tubocurarine
|
competitive, non depol, reversible with AcHE, no CNS effects
|
|
Atracurium
|
nondepol blocker, safe in hepatic and renal impariment because spon inactiavation to laudanosine( this could cause seizures)
|
|
mivacurium
|
short duration nondepol blockers
|
|
succinylcholine
|
nicotinic agonist, noncome depol blocker, no effect of AchE when desenstivzed, AE- malignant hyperthermia, hyeperkalemia, genetic polymorphism(slow metabs could be problematic)
|
|
baclofen
|
GABA B receptors, use for spasticity
|
|
dantrolene and bromocriptine
|
tx for malig hyperthermia
|
|
MAC
|
lower MAC- more potennt
|
|
blood gas ratio
|
high- slower onset and slower recovery
|
|
IV anethetics
|
thiopental, midozolam, propodol, fentanyl, ketamine
|
|
dantrolene
|
blocks Ca release from muscle SR, tx for NMS
|
|
CI in opids use
|
head injuries, pul dysfunction(except pul edema), hepatic and renal dysfucntion, adrenal or thyroid def, pregnancy
|
|
meripridine
|
opioid full agnosit, antimuscardinic, met to normepridine-->serotonin syndrome and seziures
|
|
methadone
|
maintains opioid addiction
|
|
codeine
|
cough supressant
|
|
dextromorphan
|
opid related, cough supressant
|
|
loperamide
|
opoid rel, diarrhea
|
|
opidoid management of withdrawal
|
methadone and clonidine(decreases NE release)-->decreases SANs response
|
|
opoid mgmt of acute txocitiy
|
IC nalazone
|
|
opoid withdrawal
|
yawning, lacrimation, salivation, rhinorea, CNS origin, pain, anxiety, sweating, G I coulple, u- strongest
|
|
nalbuphine and pentazocine
|
K agonist- spinal analgesia and dysphoria, u antagonist- preciptation of withdrawal
|
|
naloxone
|
opoid antagonist, IV, reverse resp dep
|
|
naltrexone
|
decrease craving of alc and opiate addiction
|
|
methylnaltrexone
|
opioid anatgonist, opioid rel constipation
|
|
DA agonist
|
dyskinesia(hyper movement)
|
|
DA antagonist
|
pseudoparkinsosm(nigrostriatal) , gynecopastia, amenoreha/galactorreha (tuveroinfedibular)
|
|
mesolimbic pathway
|
cell bodies in midbrain, reiforcement of behavior increased DA in nucelus accumbens
|
|
amporphine
|
DA agonsit, emetic
|
|
D1
|
Gs
|
|
D2
|
Gi
|
|
D2A
|
nigrostriatal
|
|
D2C
|
mesolimbic , clozapine
|
|
levodopa
|
prodrug, converted by decarbozylase, give with carbidopa(inhbits peripheral decarboxylase) AE- dyskinesia, psychosis, hypotension
|
|
tolcapone and entacapone
|
inhibit COMT and enhances uptake and effciacy, tolcapone- hepatoxic
|
|
seleginine
|
MAO B selective inhbitor, NO TYRAMINE INTERACTION AE- dyskeniea, psychosis, amnesia(met by aphetamine- will test + in drug test)
|
|
bromocriptine
|
hyperprolactinoma and acromegaly , DA receptor acgonist , AE- psychosis and dyskinesia
|
|
pramipexole and ropinirole
|
DA receptor agonist
|
|
benztropine, trihexyphenydyl, diphenhydramine
|
decreases Ach function, muscarinic blocker, decreases tremor and rigidity, AE- antimuscarinic(atropine like)
|
|
amantidine
|
antiviral, blocks muscarinin increased DA release, AE- LIVEDO RETICULARIS
|
|
antimuscarinic use in psychosis
|
for acute EPS( pseduoparkinsonism, akathesia, dystonia)
|
|
atypical antipsychotic
|
chronic EPS for tardive dyshyemia
|
|
antipyschotic AE
|
EPS, dysphoria(decreases compliance), endocrine( NMS, increased prolactin, wt gain) , hypotnesion due to alpha blockage
|
|
Typicals
|
chlorpromazine, thioridazine, fluphenazile, haloperidol
|
|
atypicals
|
clozapine, olanzapine, risperidone, aripiprazole
|
|
thioridiazine
|
better antimusacrin, incrased sedation, increased alpha blockate, cardiac toxicity(quinidine like), retinal deposits, allergies , typical antipsych
|
|
haloperidol
|
NMS and TD, typical antipsych
|
|
clozapine
|
block D2C and 5HT2, AE- agranulocystosis, NO TD, increased salivation(due to serotnin) , seziures(due to antimuscarinic) , atypical antipsychotic
|
|
olanzapie and risperidone
|
atypical, blocks 5HT2 improves negative symptoms
|
|
aripiprazole
|
partial agonist of D2, blocks 5HT2 receptors
|
|
phenelzine and tranylcypromine
|
MAOI , use- atypical depression, AE- HYPERTENSIVE CRISSI, DI with tyramine, TCA, levodopa, alpha 1 agonist, SEROTONIN SYN
|
|
serotonin syn
|
sweating, rigidity, myoclonus, hyperthermia, ANS instabiliy, seizures , Drugs- SSRI, TCA, meperidine
|
|
TCA
|
amitriptiline, imipramine, clomipramine, non specific block of 5HT and NE, DI- hypertensive crisis with MAOI, seronin syn, AE- 3 Cs(coma, convusion, cardiotoxic)
|
|
clomipramine
|
TCA for OCD
|
|
amytriptyline
|
TCA for neuropathic pain, can also use carbemazepine
|
|
imipramine
|
decreased slow wave sleep, works on phase IV of sleep, night terrors
|
|
fluoxetine, paroxetine, sertraline, citalopram, fluvoxamine
|
slective blockade of 5HT reuptake , USE- depression, anxiety, DI- CYP inh(fluvoxamine and fluxetine), benzo
|
|
citalopram
|
safe for interactions
|
|
trazodone
|
5HT agonist, AE- arrthmias, pirapism
|
|
venlafazine
|
nonselective reuptake blocker devoid of ANS effects
|
|
buproprion
|
DA reuptake blocker, used in smoking cessation
|
|
Mirtazapine
|
alpha 2 antagonist, wt gain and anorexia
|
|
lithium
|
DOC for bipolar, decreases PIP2 and camp, AE- life threatining sezures, hypothyroidsimwith goiter(decreased TSH), NDI(decreased ADH)- tx with amiloride, chronic thazide decreases clearance of LI, use K sparing, teratogenic(ebsteins- malformed tricuspid)
|
|
methylphenidate
|
amphetatime like, AE- cardio toxicity, use- ADHD
|
|
atomoxetine
|
selective NE reuptake inhibitor, USE- ADHD
|
|
amphetamine
|
block reuptake of NE and DA, relase amines from mobule pool
|
|
benzo toxcitiy
|
tx with flumazenil, cant use for barbituate toxcitiy
|
|
benzo MOA
|
potnetiate GABA with GABA A (BZ1 and BZ2)
|
|
barbituate+ alcohol
|
lif threatening seziure
|
|
marijuana
|
interact of CB 1 and CB2
|
|
PCP
|
NMDA antagonist, AE- rhabdomylosysi, convulsions and edeath
|
|
ketamine
|
hallucinations, glutamate receptro antagonist
|
|
MDMA
|
5HT, excstasy, raves
|
|
inhanats
|
solvent abuse, multiple organ damage
|
|
macrolides
|
erythromycin, azithromycin clarithromycin, USE- g+, atypicals, C jejuni, MAC, H pylori, CYP inh, AE- stim gut motilin
|
|
clarithromycin
|
macroline with less GI symptosm
|
|
azitrhomycin
|
macrolide with least CYP inh , H pyroli
|
|
telitrhomycin
|
ketoline, macrolide resistn S pneumona
|
|
clindamycin
|
not macrolide but same mechanism and resistance, G+, b fragilis and anarobes, use in osteomylitis with g+, AE- C DIFFICLE COLITIS
|
|
linezolid
|
MOA- inhibits initation complex in bac translation, prevents formation of tRNA complex, USE- tx for VRSA and VRE, drug resist penumoccoa, 50 S
|
|
quinupristin-Dalfopristin
|
50S, like tetracycline, streptogramins, binding to 50S prevent interaction of amino acyl tRNA with acceptor site , USE- VRE, VRSA
|
|
sulfonamides
|
inhibit dihydropteroate synthetase , DON’T USE ALONE- resistance
|
|
trimethoprim and pyrimethamine
|
inhibit dihdrofolate reductase , Bone marrow suprresion, problemtatic in HIV pts
|
|
sulfasalazine
|
ulcertative coilitis and rheumatoid arthritis
|
|
Ag sulfadiazine
|
burns
|
|
GI conjugases
|
carbamezipine and phenytoin, allows for transport of folate
|
|
cotrimoxazole
|
trimethoprim-sulfamethoxazole, DOC for nocardia, listeria, g- infections, g+ infections, PCP, toxoplasm, AE- allergies, take with lots of water( to avoid stones), kernicterus in babeis, phototoxciiy
|
|
chloramphenicol
|
bacteriostatic, met by hepatic glucorination, CYP inh, dose dep marrow supreesion, back up for salmonella and ricettksa, AE- GRAY BABY SYN
|
|
Doxycyline
|
lipid soluble, proststis(gonorhea+chlamydia, boreilla , hepatic met
|
|
minocycline
|
menigicoocal carrier state( rifampin more frequent- organge body fluids)
|
|
Demeclocycline
|
SIADH
|
|
tigecycline
|
MRSA and VRE skin and complicated infections
|
|
ADH
|
increased by carbamazepine, decreased by LI , decreased by demeclocyline
|
|
tetracycline
|
chelators, bacteriostatic, borad- atypicas, h pylori, ricketsia, boreilla, brucella, vibrio, treponema(back up) , AE- tooth enamel dysplsia and decreased bone , CI in preggers( liver issues)
|
|
drugs that cause photoxicity
|
tetracucline, sulfonamide, quinolones
|
|
gentamicin, tobramycin, amikacin, streptomycin
|
aminoglycosides, AE- nephrotoxicity(ATN) , otoxicity, NEUROMUSCLAR BLOCKADE , once daily dosing
|
|
streptomycin
|
TB, DOC for bubonic plague and tularemia
|
|
CI in pregancy
|
aminoglycosides, fluroquinolones, sulfonamides, tetracycline
|
|
aminoglycosides(30S), linezolid(50S)
|
interenes with initiation, misreading of code(aminoglycosdies only- cidal)
|
|
tetracycline (30S)and dalfopristin/quinupristin (50S)
|
blocks attachemnt of aminoacyl tRNA to acceptor site(static)
|
|
chloramphenicol (50S)
|
inhibit the activity of peptidyl transferase(-static)
|
|
macrolides and clindamycin (50S)
|
ihibits translocation of peptidyl tRNA from acceptor to donor site
|
|
otoxoic
|
aminoglycosides, loop diuretics(ethycrinic acid more) , vancomycin
|
|
vancomyci
|
binds Dala Dala and hinders the transglyclation and invovlved in the elognation of peptidoglycan chains, NO ROLE IN PBPs, USE- MRSA, enterococci C difficiel(not DOC, metronizadle is) , resistance- termanial Dala is replaced by D lactate, orally for colitis, AE- red man syndrome, otoxotic
|
|
aztreonam
|
resistant to B lactmases, no cross allogeniencity, ONLY G-
|
|
Imipenem and Meropenem
|
Reistant to B lactams, nosocmial epiric for life threathening, give with CILASTATIN to prevent RENAL TOXCITIY , USE- enterobacter and pseudomonas, AE- seizures
|
|
cefazolin, cephalexin
|
first gen cephalosporin, surgical prolylacis, g+, NO ENTRY INTO CNS, long half life
|
|
cefotetat, cefaclor, cefuroxime
|
second gen cephalospin, cefuroxime enters CNS
|
|
ceftriazone, cefotaxime, cefdinir, cefixime
|
g+, g- rods and coci, epiric for menginitis and spesisi
|
|
cefipime
|
IV, reistant to beta lactamase, wide spect, enters CNS
|
|
cefoperazone, ceftriazole
|
bile eleminated
|
|
cefotetaan, cefoperazone
|
disulfiram like
|
|
inhibition of bacterial cell well synthesis
|
pencillins, cephalosporin, imipenem/meropenem, aztrenam, vancomycin
|
|
ihibitoion of bacterial protein sysntehsis
|
aminoglycosides, chloramphenicol, macrolindes, tetraclylines, strepgtamins, linezolid, clindamycin
|
|
inhibition of nucelic syntehsis
|
fluoroquinilone, rifampin
|
|
inhibition of folic acind syntehsis
|
sulfonamide, trimethoprim, prymethamine
|
|
pencillin and cephalosporins reistance
|
production of B lactamases, which cleave the beta lactam ring structure, change in PBPs, change in porin
|
|
aminoglycosides resistance
|
conjugate rxns that transfer acetyl, phosphoryl, adenyl groups
|
|
macrolides resistance
|
formation of methyltransferases that alter drug binding sites on 50S, active transport out of cells
|
|
tetracyclines resistance
|
increased pumping drug out of cell
|
|
sulfonamides resistance
|
change in sensitivty of inhibiton of target enzyme, increased PABA formation, exogenous folic acid
|
|
fluroquinilone resistance
|
change in sensivity to ninhbition of target enzymes, increased activity of transport systems that promote drug efflux
|
|
chloramphenicol resistance
|
formation of activating acetyl transferase
|
|
pencillin
|
interacts with cytoplasmic membrane binding proteins to inhibit transpeptidation reaction invovled in cross linking, AE- hypersensivity, interstitial nephritis with methicillin, JHR rxn with tx of syphulis(flushing joint pain, proof tht drug is working- used to be assessment too in olden days)
|
|
nafcillin, methicillin, oxacimmin
|
betalacatase resistant, staph
|
|
benzathine
|
long acting , pencillin G
|
|
amoxicillin
|
boreilla, H pylori
|
|
ampicllin
|
listeria
|
|
ticarcillin, piperacillin, azlocillin
|
extended spectrum, antipseudomonal, betalactamase sensitive
|
|
clavunic acid and sulbactam
|
irreversible B lactamase inhibitors
|
|
naficillin and oxacillin
|
eliminated via bile
|
|
quinilones
|
ciprofloxacin, levofloxacin, MOA- bacteriacidal, interfere with DNA syntehsis, inhibit top II, USE- UTI res to cotromixazole, oral tx for gonnia(1 disoe), skin, soft tissue and bone infections, Diarreha resistant to cotrimixazole(salmonella, shigella, e coli, campylobacter, DONT take with meals, CI in pregnancy, AE- tenodinits, tendon rupture
|
|
metroniddazole
|
DOC for giardia, trichomonas, entamoeba, AE- metallic taste, disulfiram like effect
|
|
isoniazid
|
anti TB, inhibits mycolic acid syn(only in TB), resistance- del in katG, AE- hepatitis, peripheral neuricts(due to B6 def), SLE
|
|
rifampin
|
anti TB, inhibits DNA dep RNA pol, red orange metabolites, 450 induction
|
|
ethambutol
|
inhbits syn of arabinaglactan(cell wall comp), decreases red green visual acuity, anti TB
|
|
streptomycin
|
anti TB, AE- deafness, nepthroxic
|
|
ampoteracin B
|
interactis with ergosterol and forms pores in membres, disrupt membraine permeabiltiy, DOC for systemic infections fungal , IV, poor BBB penetration so need to use it intrathecally, slow clearlance, AE- nefphrotoxic(looks like CRF)
|
|
nyastatin
|
topically for local infeciotn, swish and swallow for candiasi, too toxicy for systemic
|
|
azoles
|
inhibits 14 alpha demytylase which converts lanestrol to ergosteron, preferred to amph when possible due to less toxicity, AE- gynecomastia, LFTs , CYP inhibitors
|
|
ketoconazole
|
DOC for histo para and balsto(preferrered to ampho due to less txocitiy) , decreased absoprtion by antacids
|
|
fluconazole
|
DOC for esophageal and invasive candiasis, crypotcoall meningits prohpylactic , CAN CROSS BBB
|
|
Itraconazole and voriconazole
|
DOC for blastomyces, sporotrichoses, aspergilloses , itra- increased absoprtion by food
|
|
flucytosine
|
cytosine deaminase to 5-FU, 5 FU forms 5Fd UMP which inhibits thymidylate synthase which decreases thymine
|
|
griseofulvin
|
acts only against dermatophytes, AE- disufliram rxn
|
|
terbinafine
|
only dermatphytes, inhibits squalene epoxidase
|
|
amantidine, enfuvirtide, maraviroc
|
block viral penetration/ uncoating
|
|
acyclovir, foscarnet, ganciclovir
|
inhibit viral DNA polymerases
|
|
foscarnet, ribavirin
|
inhibit viral RNA polymerases
|
|
zidovudine, didanosine, zalcitabine, lamivudine, stavudine, nerviapine, efavirenz
|
inhibit viral reverse transcriptase
|
|
idinavir, ritonavir, saquinivir, nelfinavir
|
inhibits viral asparate protease
|
|
zanamivir, oseltamivir
|
inhibits viral neuraminidase
|
|
acylovir
|
viral thymidine kinase, HSV, VZV, AE- NOT HEMATOXIC, neurotxic and crystalluria , chain termination because lacks OH group , res due to change in kianse
|
|
ganciclovir
|
viral specific thymidine kihase, phophotransferase(UL97) in CMV, causes chain termination, USE- mostly for CMV prophylacis for retinitis in AIDS and transplant pts , AE- DOSE LIMITING HEMATOXICITY , SEIZURES
|
|
Foscarnet
|
inhibits viral DNA and RNA pol, dose limiting nephrotxicity, avoid pentamidine IV(increases nephrotoxicity and hypocalcemia- used for PCP) , USE- acyclovir res strains of HSV
|
|
NNRTs
|
do not reuqire metabolic activation- nevirapine and efavirenz, inibits RT at another site different from NRTI bidning
|
|
Zidovudine , AZT
|
phosphyrlated nonspecifically to triphospate that can inihibit RT, chain termination , AE- hematoxic, don’t use with stavudine
|
|
Didanosine , DDI
|
NRTI, AE- pnaacreatitis, don’t use with zalcitabine
|
|
zalcitabine , DDC
|
peripheral neurophaty , don’t use with diadanosine
|
|
stavudine, D4T
|
meylosuppresion and periphjeral nuerppathy , don’t use with zidovudine
|
|
lamivudine, 3TC
|
least toxic, active in Hep B
|
|
indinavir
|
protease inhibitor, cleaves precursor polypetides in HIV so mature portines cant form, resistance due to pt mutation in pol gene, AE- crystalluria
|
|
ritonavir
|
protease inhibhitor, induces and inhbits CYP, can lead to type II diabetes and cardiovasvual dsiease
|
|
raltegravir
|
integrase inhibitor , prevents integration of viral genome in host cell
|
|
enfuviritide
|
binds to gp41 and inhbits fusion of HIV1 and CD4
|
|
maraviroc
|
blocks CCR5 protein on macrophages to prevent viral entry
|
|
amantidine
|
blocks attachment, penetration and unconatinng of infleunza A, AE- livedo reticualris
|
|
zanamivir, oseltamivir
|
inhibits nueromainase A and B, propylaictic fro infleuncza
|
|
Ribivarin
|
inhibits viral RNA pol, RNA viruses(RSV, lasssa), AE- hematotxic
|
|
Antitumor interforms
|
kaposi(intf gamma)
|
|
Cyclophosphamide
|
antiCA, alkylating agent attacks guanine N 7, USE- NHL, breast ca, neurobasltoma, AE- hemoraggic cystitis(tx with mesna)
|
|
mesna
|
tx hemoragic cystitc causes by cyclophosphamide
|
|
cisplatin
|
anticCA, alkymates DNA, USE- testicular, ovarian, bladder, lung CA, AE- nephrotoxic and neurotoxic(use amifostine for kindesy)
|
|
amifostine
|
tx nephrotoxicity with cisplatin
|
|
procarbizine
|
antiCA, hodgkins
|
|
Doxirubucin
|
atti CA, MOA- antitumor antovdy, AE- cardiotoxcity, free radical gen, USE- HL, breast, lung, endomet, dilated cardiomyopathy
|
|
Methotrexate
|
DHF reducatase inh(S phase), USE- lymphoma and lukemia, RA and psoriasis, rescue with leucoverin
|
|
5-Flyroyracin
|
pyrimidine antimetabolite( S sphase) to inhibit thymidylate synthetase, colorectal CA
|
|
6-Mercaptopurine
|
purine antimetabolite, USE- ALL, increaed gout with allopurinol
|
|
Bleomycin
|
complexes with Fe and O2, G2 phase, USE- HL, testicular, head, neck, skin CA, pneumonitis, pul fibrosis
|
|
viblastin and vincristine
|
decrease microtubular polym( Mphase) , vinblastin- BMS, vincristine- neurotoxic, USE- vinblastic( HL, testicular, kaposi), Vincritine(HL, testicular, wilms)
|
|
ATRA
|
differentiating agent, t(15;17) differntiation syndrome(resp distress, plerual, pericardial effucsion)
|
|
Renal toxcitiy
|
cisplatin, methotrexate
|
|
pulmonary toxicity
|
bleomycin, busulfan, procarbizine
|
|
cardiac toxcitiy
|
doxarubicin, danurubicin
|
|
neurologic toxicitiy
|
vincristine, cisplatin
|
|
immunosuppressive
|
cyclophosphamide, methotrexate
|
|
Filgrastim
|
increased granulocytes
|
|
Sargromostin
|
increased granulocytes and macrophages , AE- CAPILLARY LEAKAGE SYN
|
|
imatinib
|
tyrosine kinase inhibitor, used for CML, inhibits bcr abl t(9,22)
|
|
ANTICA with no BMS
|
cisplatin, bleomycin, vincritine, asperginase
|
|
asperginase
|
AE- pancreatitis
|
|
lomustine, carmustine
|
crosses BBB, used for glioma
|
|
charcoal
|
AD for all other positings
|
|
vit K
|
AD for warfarn
|
|
atropine+pralidoxime
|
organophohphates , ACH2 inhibitors AD
|
|
Deforoxamine
|
AD for iron and salts
|
|
digoxin immun Fab
|
AD for digoxin
|
|
Dimercaprol
|
AD for Arshenic, gold, mercury, lead, oral succimer for milder lead and milder mercury toxicity
|
|
EDTA
|
AD for Cd, Cr, Co, Mn, Zn toxicity
|
|
Esmolol
|
AD for theyophyline, beta agonsits
|
|
Ethanol, fomepizole
|
AD for methoanol or ethylene glycol
|
|
flumanezil
|
AD for benzo
|
|
naloxone
|
AD for opoids
|
|
100% oxygen
|
AD for CO
|
|
pencillamine
|
AD for Cu
|
|
protamine
|
AD for Heparin
|
|
acetylcysteine
|
AD for acetaminophn
|
|
gingki
|
intermittent claudication and alzeimers, use in cuation with anticoags
|
|
saw palmetto
|
tx of BPH, 5 alpha reductase inhibitor and androgen receptor antagonist
|
|
St johns
|
serotonin syndrome, enhaces 5HT, interaction with antidepresants
|
|
abciximab
|
antagonist of IIb/IIIa receptors
|
|
infliximab
|
RA and CD , binds to TNF
|
|
trastuzumab
|
breast CA, ERB2(Her 2/neu)
|
|
rituximab
|
NHL, binds to surface protein
|
|
Interferon alpha
|
Hep B, C, lukemia, melanoma
|
|
Interferon beta
|
MS
|
|
Interferon gamma
|
CGD increases TNF
|
|
azithioprine
|
immunosupressant converted to 6- mercaptourine
|
|
cyclosporine
|
DOC for organ or tissue transplant , binds to cycophilin
|
|
Tacrolimus
|
alt to cylosporine , MOA- FK binding protein
|
|
alendronate
|
DOC for glucocroticoid induced ostoporosis
|
|
bisphonates
|
stabilzies hydroapatite, ends in ronate, for paget disease
|
|
teriparatide
|
recombinant DNA PTH analog, once daily, AE- continuous infusion stimulate osteoclast activity , increased risk of osteosarcoma
|
|
octreotide
|
somatostatin
|
|
somatropin
|
GH
|
|
cosyntropin
|
ACTH
|
|
leuprolide, nafarelin
|
GnRH
|
|
Propylthiouracil and methomazole
|
hyperthyroidism, PTU safer in pregnancy , inhibts oxidation, coupling, iodination, conversion of T3 to T 4
|
|
Flutamide
|
androgen receptor blocker for prostate CA
|
|
Leuprollide
|
GnRH analog, androgen receptor+ prostate cancer
|
|
Finasteride
|
5 alpha reductase inhibitor, USE- BPH and male pattern baldness
|
|
OCPs
|
increased risk of liver adenoma, complication- retroperitoneal bleeding
|
|
oxandrolone, nandrolone
|
androgens, male hypogonadism, use in atheles, AE- aggresion and cholestatic jaundice
|
|
norethindone
|
progestin, AE- hursuitisim
|
|
Raloxifene
|
no increased risk of endometrial cancer
|
|
clomiphene
|
fertility pill, decreases feedback inhnition, AE- multile births
|
|
Anastrazole
|
post menopausla breast CA
|
|
mifepristone
|
morning after pill, blocks glucocorticoid and progestin receptors
|
|
metyrapone, ketoconazole
|
blocks 11 hydroxylation
|
|
Exenatide
|
releases incretin, increases insulin secretion, GLP1 full agonist,
|
|
Sitagliptin
|
inhibits dipeptidyl peptidase, inhibits activaiton of GLP-1
|
|
pramilintide
|
synthetic version of amylin- slows rate of food absorption and decreases appetite
|
|
Pioglytazone and rosiglitazone
|
binds to PPAR increases sensitixation to isulin on genetic level, AE- less hypoglycemia than sufonynureas, wt gain, edema
|
|
acarbose
|
inhibits alpha glucosidase in brush borders of small intestince-->decreased absoprtion, AE- hepatoxic
|
|
metformin
|
increases tissue snesitivty to insulin and decreases hepatic gluconeogenesis, AE- lactic acidosis
|
|
repaglinide
|
stimuates insulin release from pancreatic beta cells
|
|
Acetohexamide, tolubutamide, chlorpromide
|
first generation sulfonylureas, chlorpomide(SIADH/disulfiram rxn)
|
|
glipizide, glyburide
|
second gen sulfonylureas
|
|
sulfonylureas
|
block K channles-->depolariozation-->insulin rlease, AE- hypoglycemia and wt gain, lots of DI(cimetidien, saliclylates, sulfonamides)
|
|
hypoglycema rxn
|
lip tonging, lethargy, confusion, sweats, tremors, coma, seizure
|
|
glargine
|
insulin analog with no peak
|
|
Abicimab, eptifibatide, tirofiban
|
Iib/IIIa antagonist, used for acute coronary syndrome (antiplatelet)
|
|
ticlopidine and clopidogrel
|
block ADP receptors on platelets, decreased activation (antiplatelet)
|
|
aspirin
|
prophylaxis for atrial arrthmias and TIAs, COX inh
|
|
streptokinase
|
thrombolytic, depetes circulating V and VIII
|
|
altepllase
|
trhomolytic clot specific
|
|
argatroban
|
used in HIT , direct thormbin inhibitors
|
|
Dabigatran
|
atrial fib
|
|
Bivalurudin
|
unstable angina
|
|
Warfarn
|
small, vit K deriv, oral, decreases hep syn of vit K factors, PT, fresh forozen plasma or vit K as tx, long term,AE- skin necrosis
|
|
Heparin
|
large, parenteral, PTT, tx- protamine sulfate, rapid, AE- HIT hypersensitivity
|
|
Theophylline
|
inhibits adenosine(prevents bronchoconstriction) and decreases PDE which increase cAMP and lead to bronchodilation
|
|
ipratropium
|
DOC for B blocker bronchospasm
|
|
cromolyn and nedocromil
|
prevents degran of pul mast cells and decreases release of histamine
|
|
lukasts
|
LTD4 antagonists, astham prophylactic
|
|
acute astham tx
|
B agonsits, theophylline
|
|
chronic astham tx
|
ipratropum, lukasts, zilueton
|
|
zileuton
|
selective LOX inhibitor
|
|
bexametasone, dexamethasone
|
glucocorticoids, decreases PGs and LTs, antiinf and immunisupression, AE- iatrogenic cushingoind syn, cortical atrophy, osteoporosis, electolyte imbalance
|
|
colchicine
|
binds to tubulie and decreases microtubular polyerzaiton
|
|
sulindac
|
NSAID with no renal effect, used for gout
|
|
allpurinol
|
prodrug that is converted by xanthine oxidase inhibits enzyme, decreases purine metablism decreases uric acid , AE- hypoxanthine stones, DI- inhinits 6-Mercaptopurine, used for chonic gout
|
|
probenecid
|
inhibits proximal tubular reabsorption of urate
|
|
acute gout
|
colchicine, NSAID, intracrutcalr steroids( cochilicine has lots of AE)
|
|
hydroxychloriquine
|
stabilizes lysosomes and decreases cehmostaxis, hemolysis in G6PD pts, used for RA
|
|
Methotrexate
|
cytotxoci to lymphocytes, hematoxicity
|
|
sulfasalazine
|
hemolysis in G6PD, for RA
|
|
RA drugs
|
hydroxychloruine, methotrexate, suflasalazine, glucocorticoids, gold salts, pencillamine, leflunamide, etanercept, inflixmab
|
|
glucocortioics
|
AE- cushoid syndrome, used for RA
|
|
gold salts
|
RA, AE- dermatatitis, hematoxicity, nephrotici
|
|
pencillamine
|
wilsons idsease, RA
|
|
leflunomide
|
inhibts DHOD, AE- alomeida, USE- RA
|
|
etanercept
|
binds TNF, infections, RA
|
|
anaakinra
|
IL1 receptor antagonist
|
|
RA drugs
|
NSAID initially(do not affect progresion just pain and inf) then put on DMARDs
|
|
metroniddazole
|
amebiasis, giardiasis, trichomoniasis, toxoplasmosis, leishmaniasis, trypanosomiasis
|
|
antimalarial prophylaixs
|
chloroquinine +primiquine( p vivax and povale)
|
|
leisbmaniasis
|
stibogluconate
|
|
trypnosmoasis
|
african(arsenicals) and nifurtomox(chagas disease)
|
|
chloroquin resistant mamalira
|
prophylkaxis- mefloquine, tx- quinine, AE- hemolytic anemia
|
|
mebendazole
|
nematodes , decreased glucose uptake and microtubular structure
|
|
praziquantel
|
tapeworms and flukes , increased Ca and increased vaculoization
|
|
pyratel pamoate
|
spastic paralysis
|
|
diphenhydramine
|
muscarnic blocker, sedatibe, antimotion
|
|
antihustamines
|
most block M receptors, are sedative and are antimition
|
|
loratidine and fexofenadie
|
antihismatines with NO CNS entry, no sedation and not anti mition sickess
|
|
H1 actication
|
capilalary dilation, increased permanility, decreased AV conduction
|
|
H2 activation
|
increased gastric acid secretion, increased SA node rate
|
|
cimetidine and ranitidine
|
H2 antagonists, supresses secretory resposnes to food, USE- PUD, GERD, ZE syndrome
|
|
cimetidine
|
H2 antaognist, CYP inh, gynecomastia and decreased libido
|
|
omeprazole
|
PPI, irreversible
|
|
misoprostol
|
PGE1 analog, increased mucus and bicarb secretion, decreased HCl secretion, NSAID induced ulcers, CI in pregnacy
|
|
sucralfate
|
protective gel like coating, antacids will interfere
|
|
bismuth subsalicylate
|
binds selectively to ulcer, coating and protecting it from acid and pepsin, BMT regimen
|
|
AlOH
|
antacid, constimation
|
|
MgOH
|
diarrhea
|
|
odansteron
|
5HT3 antagonist, antiemetic for chemo
|
|
antimetiec
|
5HT3 atnagaonsit, DA antagonist, H1 antagonist, muscarinic antagonsit, cabbinoids
|
|
apretipitant
|
NK receptor atntagonist, antiemetic
|
|
prochlorperazine, metoclopromide
|
DA antagonists , antiemetic
|
|
diphenhydramine, meclizine, promethazine
|
H1 antagonist , antiemetic
|
|
buspirone
|
partial agonsit at 5HT1a, GAD
|
|
sumatriptan
|
5HT1d decreases migraine pain
|
|
olanzapine
|
5HT2a antagonist, decreases symptoms of psychosis
|
|
cyproheptadine
|
5HT2 antagonist, used in carcinoid
|
|
ergotamine
|
partila agonist at alpha and 5HT2, vasoconstrctive, AE- abortion, gangene, ischemia
|
|
ergonovine
|
uterine smooth muscle contraction
|
|
carcinoid marker
|
5 HIAA- hydroxyindoleacetic acid
|
|
alrpostadil
|
mainatinas PDA, CI in pregnancy
|
|
dinoprostone
|
cervical rempening, abortifacient , PGE2
|
|
carboprost
|
PGF2alpha, abrotfacient
|
|
latanoprost
|
tx of glaucoma, decreased intraocular pressure
|
|
epoprostenol
|
PGI2, USE- pul HTN
|
|
aspirin
|
covalent bond via acetylation of a serine hyproxyl group near active site , antiplatetlet aggregiation- low dose, antiinfl- high dose, uncoupling of oxidative phosphryation, 0 order kinetics, alkanize urine , AE- reyes syndrome, angioedema, salycylism- vertigo, tinnitus, ringing,
|
|
celecoxib
|
cox 2 inhibitor , prothrombotic effects
|
|
acetaminophen
|
analgesic and antipyretic, hepatoxic, ethanol enhances liver toxicity , N acetylcysteine- antidote
|